Showing results (1321-1330 of 1,498) with videos related to

Sort By:
Pageof 150
BMJ Open|November 16, 2017
Does the impact of a plant-based diet during pregnancy on birth weight differ by ethnicity? A dietary pattern analysis from a prospective Canadian birth cohort allianceMichael A Zulyniak, Russell J de Souza, Mateen Shaikh, et al.
JACC. Heart Failure|May 11, 2020
Myocardial Infarction in Heart Failure With Preserved Ejection Fraction: Pooled Analysis of 3 Clinical TrialsJonathan W Cunningham, Muthiah Vaduganathan, Brian L Claggett, et al.
Annals of Indian Academy of Neurology|May 9, 2012
Need for a national epilepsy control programM Tripathi, D C Jain, M Gourie Devi, et al.
Pain|November 16, 2017
Clinical trial designs and models for analgesic medications for acute pain in neonates, infants, toddlers, children, and adolescents: ACTTION recommendationsGary A Walco, Ernest A Kopecky, Steven J Weisman, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 19, 2022
Rivaroxaban with Aspirin Versus Aspirin for Peripheral Arterial Disease and Intermittent Claudication. Rationale and Design of the COMPASS CLAUDICATION TrialEduardo Ramacciotti, Leandro Barile Agati, Giuliano Giova Volpiani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2022
Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancerD Gale, K Heider, A Ruiz-Valdepenas, et al.
Clinical Therapeutics|August 25, 2005
Analgesia and anesthesia for neonates: study design and ethical issuesK J S Anand, Jacob V Aranda, Charles B Berde, et al.
Pediatrics|June 17, 2006
Summary proceedings from the neonatal pain-control groupKanwaljeet J S Anand, Jacob V Aranda, Charles B Berde, et al.
Journal of the American College of Cardiology|July 2, 2021
Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery DiseaseJohn W Eikelboom, Deepak L Bhatt, Keith A A Fox, et al.
JAMA Network Open|June 22, 2022
Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity RevascularizationConnie N Hess, Michael Szarek, Sonia S Anand, et al.
Pageof 150